(Q40693534)

English

Clinical experience with moxonidine

scientific article published on March 1994

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

1 reference

Europe PubMed Central

Clinical experience with moxonidine (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

B N Prichard

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

publication date

1 March 1994

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Cardiovascular Drugs and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

8 Suppl 1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

49-58

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Hemodynamic and neurohumoral effects of moxonidine in patients with essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraindividual comparison of moxonidine and prazosin in hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of moxonidine and clonidine HCl in treating patients with hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Crossover comparison of moxonidine and clonidine in mild to moderate hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Long-term experiences with moxonidine, a new antihypertensive agent]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that different regional sympathetic outflows vary in their sensitivity to the sympathoinhibitory actions of putative 5-HT1A and alpha 2-adrenoceptor agonists in anaesthetized cats

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Moxonidine. A review of its pharmacology, and therapeutic use in essential hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Unique presynaptic alpha 2-receptor selectivity and specificity of the antihypertensive agent moxonidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacodynamic action and pharmacokinetics of moxonidine after single oral administration in hypertension patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/8068579

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00877084

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40693534&oldid=1904864840"